L-2-Aminobutanol-d5
Product Description
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
Categories
Specifications
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
More Products from CLEARSYNTH LABS LIMITED (62)
-
Product Deutetrabenazine Intermediate - 2-(3,4-bis(methoxy-d3)phenyl)ethan-1-amine
2-(3,4-bis(methoxy-d3)phenyl)ethan-1-amine is an advanced deuterated intermediate essential for the commercial synthesis and manufacturing of Deutetrabenazine (API) -
Product Lisdexamfetamine Dimesylate
Lisdexamfetamine Dimesylate is a central nervous system (CNS) stimulant active pharmaceutical ingredient (API) and prodrug indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and binge eating disorder (BED). Enzymatically hydrolyzed in red blood cells to release active dextroamph... -
Product Deuterated Products
Specialised in Deuterium Chemistry, Clearsynth Manufactures Deuterated Reagents, Deuterated Intermediates and Deuterated APIs (such as Deutetrabenazine, Deuruxolitinib, Deutivacaftor, Deucravacitinib, Donafenib)
Production capacity from mg to tons scale.
Our key reagents are Benzene D... -
Product Nitrosamine and Drug Impurities | Testing and Analytical Services
Clearsynth is a globally trusted partner for reference standards and research chemicals. We offer over 3,000 nitrosamine impurities, 5,000+ stable isotopes, and 10,000+ drug impurities, encompassing a vast portfolio of more than 325,000 products serving various industries, including pharmaceuticals, clinic... -
Product Reference Standards and NMR Solvents
Clearsynth is Globally Trusted Partner for Reference Standards and Research Chemicals. An extensive range of 325,000+ products serves various industries such as pharma, clinical research, testing laboratories, etc. We specialize in Innovative Organic Chemistry and synthesis of Unique Complex Molecules, St... -
Product rac-cis-Ambroxol-d5
Labelled anaologue of cis-Ambroxol, the cis-isomeric impurity of Ambroxol. cis-Ambroxol is a metabolite Bromhexine. -
Product Amisulpride-d5 N-Oxide
Labelled Amisulpride N-Oxide. Amisulpride N-Oxide is an impurity of Amisulpride. Amisulpride N-Oxide was identified as a photodegradation product of Amisulpride. -
Product Amyl Phthalate-d4
Amyl Phthalate-d4 is the isotope labelled analog of Amyl Phthalate. Amyl Phthalate, is a Phthalate esters (PEs) acting as a plasticizer compounds that are widely used for many consumer product applications. It is also known to to induce male fetal endocrine. -
Product ABT 263-d8
A novel inhibitor of antiapoptotic BCL-2 proteins; a new promising anticancer drug candidate. -
Product Aldicarb-d3 Sulfoxide
It is a Labelled Aldicarb Sulfoxide. Aldicarb Sulfoxide is an analog of Aldicarb detected in agricultural products as pesticide residue. -
Product N-desmethyl Sildenafil D8
Labeled Sildenafil, intended for use as an internal standard for the quantification of Sildenafil by GC- or LC-mass spectrometry. -
Product Tretinoin
An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT.
CLEARSYNTH LABS LIMITED resources (1)
-
Video Clearsynth Intro Video
Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.











